-
-
No events on calendar for this bill.
-
Representative Carla D. Cunningham(D)
Representative Gale Adcock, FNP(D)
Representative Wayne Sasser(R)
Representative John Ager(D)
Representative Kelly M. Alexander, Jr.(D)
Representative John Autry(D)
Representative Amber M. Baker(D)
Representative Kristin Baker, M.D.(R)
Representative Cynthia Ball(D)
Representative Mary Belk(D)
Representative John R. Bradford, III(R)
Representative Cecil Brockman(D)
Representative Terry M. Brown Jr.(D)
Representative Deb Butler(D)
Representative Becky Carney(D)
Representative Allison A. Dahle(D)
Representative Terence Everitt(D)
Representative Brian Farkas(D)
Representative Susan C. Fisher(D)
Representative James D. Gailliard(D)
Representative Rosa U. Gill(D)
Representative Charles Graham(D)
Representative Wesley Harris, PhD(D)
Representative Pricey Harrison(D)
Representative Rachel Hunt(D)
Representative Howard J. Hunter, III(D)
Representative Verla Insko(D)
Representative Joe John(D)
Representative Abe Jones(D)
Representative Carolyn G. Logan(D)
Representative Marvin W. Lucas(D)
Representative Nasif Majeed(D)
Representative Marcia Morey(D)
Representative Ben T. Moss, Jr.(R)
Representative Garland E. Pierce(D)
Representative Amos L. Quick, III(D)
Representative James Roberson(D)
Representative Raymond E. Smith, Jr.(D)
Representative Evelyn Terry(D)
Representative Brian Turner(D)
Representative Michael H. Wray(D)
Representative Lee Zachary(R)
-
Ref To Com On Rules and Operations of the SenateSenate | 2021-05-12Passed 1st ReadingSenate | 2021-05-12Regular Message Received From HouseSenate | 2021-05-12Regular Message Sent To SenateHouse | 2021-05-12Passed 3rd ReadingHouse | 2021-05-11Passed 2nd ReadingHouse | 2021-05-11Added to CalendarHouse | 2021-05-11Cal Pursuant Rule 36(b)House | 2021-05-11Reptd FavHouse | 2021-05-11Re-ref Com On Rules, Calendar, and Operations of the HouseHouse | 2021-05-10Withdrawn From ComHouse | 2021-05-10Re-ref Com On InsuranceHouse | 2021-05-04Reptd FavHouse | 2021-05-04Ref to the Com on Health, if favorable, Insurance, if favorable, Rules, Calendar, and Operations of the HouseHouse | 2021-04-13Passed 1st ReadingHouse | 2021-04-13FiledHouse | 2021-04-08
-
CANCER
COUNCIL OF STATE
DISASTERS & EMERGENCIES
DISEASES & HEALTH DISORDERS
HEALTH SERVICES
INSURANCE
INSURANCE DEPT.
INSURANCE
HEALTH
PUBLIC
PUBLIC HEALTH
PUBLIC OFFICIALS
INSURANCE COMMISSIONER
PUBLIC HEALTH EMERGENCY
-
58-3-167 (Sections)
-
No counties specifically cited.
-
-
-
H524: Oral Chemo Treatment Access During Pandemic. Latest Version
Session: 2021 - 2022
AN ACT to require coverage for orally administered anticancer drugs during COVID‑19 STATE OF EMERGENCY.
Whereas, in recent years, oral chemotherapy treatments have been developed that provide viable alternatives to traditional intravenous cancer treatments for patients; and
Whereas, this oral chemotherapy treatment offers the treating physician and the patient a choice in relation to treatment options; and
Whereas, this choice is sometimes limited as the oral chemotherapy treatments are in most cases covered under the prescription drug benefit of an insurance plan rather than under the major medical insurance benefit of an insurance plan; and
Whereas, the public health emergency makes it difficult for some patients to travel for traditional intravenous cancer treatment; Now, therefore,
The General Assembly of North Carolina enacts:
SECTION 1. The following shall apply to every health benefit plan offered in this State, as defined under G.S. 58‑3‑167, that provides coverage for prescribed, orally administered anticancer drugs that are used to kill or slow the growth of cancerous cells and that provides coverage for intravenously administered or injected anticancer drugs:
(1) The health benefit plan shall provide coverage for prescribed, orally administered anticancer drugs on a basis no less favorable than the coverage the plan provides for intravenously administered or injected anticancer drugs.
(2) Coverage for orally administered anticancer drugs shall not be subject to any prior authorization, dollar limit, copayment, coinsurance, or deductible provision or to any other out‑of‑pocket expense that does not apply to intravenously administered or injected anticancer drugs.
SECTION 2. The Commissioner of Insurance shall have the authority to enforce the provisions of this act and may adopt temporary rules to implement this act.
SECTION 3. An insurer offering a health benefit plan in this State shall not achieve compliance with this section by reclassifying anticancer drugs or by increasing patient cost‑sharing, including any coinsurance, copayment, deductible, or other out‑of‑pocket expenses imposed on anticancer drugs. Any health benefit plan change that increases an out‑of‑pocket expense applied to anticancer drugs must also be applied to the majority of comparable medical or pharmaceutical benefits covered by that health benefit plan.
SECTION 4. This act becomes effective when it becomes law and expires 60 days after the date Executive Order No. 116, Declaration of a State of Emergency to Coordinate Response and Protective Actions to Prevent the Spread of COVID‑19, expires or is rescinded.